JAGX

Jaguar Animal Health, Inc. (JAGX) is a commercial-stage biopharmaceutical company headquartered in San Francisco, focused on developing innovative prescription therapies for both human and animal health, with a primary emphasis on chronic gastrointestinal disorders and debilitating diarrhea. Utilizing proprietary technologies rooted in extensive research of the gastrointestinal microbiome, Jaguar Health is committed to delivering effective and sustainable healthcare solutions that enhance the quality of life for patients and their pets. As the demand for effective treatments in the gastrointestinal market continues to rise, Jaguar Health's advancements position it as a significant player in the biopharmaceutical landscape.